MacroGenics Inc to Discuss MARGENZA™ Approval - Conference Call Transcript
Good morning. We will begin MacroGenics call in just a moment. (Operator Instructions)
At this point, I will turn the call over to Jim Karrels, Senior Vice President and Chief Financial Officer of MacroGenics.
Thank you, operator. Good morning, and welcome to MacroGenics' conference call to discuss the recent FDA approval of MARGENZA for patients with pretreated metastatic HER2-positive breast cancer. We encourage you to read yesterday's full press release available under the Investors tab of our website as well as the full prescribing information, including the box warning at www.margenza.com.
Also under the Investors tab of our website, on the Events and Presentations page, you'll see a link to a downloadable PDF of this morning's presentation. You can listen to this conference call via webcast on our website where it will be archived for 30 days beginning approximately 2 hours after the call is completed.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
